Aldose reductase: a window to the treatment of diabetic complications? (Q47721742)

5 February 2018

review article

1 reference

title

Aldose reductase: a window to the treatment of diabetic complications? (English)

1 reference

5 February 2018

author name string

Crabbe MJ

series ordinal

1

1 reference

5 February 2018

Goode D

series ordinal

2

1 reference

5 February 2018

publication date

1 July 1998

1 reference

5 February 2018

Progress in Retinal and Eye Research

published in

1 reference

5 February 2018

volume

17

1 reference

5 February 2018

page(s)

313-383

1 reference

5 February 2018

issue

3

1 reference

5 February 2018

Effect of an aldose reductase inhibitor on type IV collagen production by human endothelial cells cultured in high glucose

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The amine oxidases of human placenta and pregnancy plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Chemical modification studies on purified bovine lens aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Five new C-methyl flavonoids, the potent aldose reductase inhibitors from Matteuccia orientalis Trev.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Human placental aldose reductase: role of Cys-298 in substrate and inhibitor binding

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

4-Nitrophenol UDPglucuronyltransferase (rat liver)

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

CATARACT AND DIABETES.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Different effects of two aldose reductase inhibitors on nociception and prostaglandin E.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Inhibition of macrophage chemotaxis and peripheral nerve regeneration in normal and hyperglycemic rats by the aldose reductase inhibitor Tolrestat

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Occurrence of glutathione-modified aldose reductase in oxidatively stressed bovine lens

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Residues affecting the catalysis and inhibition of rat lens aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldose reductase and p-crystallin belong to the same protein superfamily as aldehyde reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Modification of aldose reductase by S-nitrosoglutathione

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldose reductase (EC 1.1.1.21) activity and reduced-glutathione content in lenses of diabetic sand rats (Psammomys obesus) fed with acarbose

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Kinetic characteristics of ZENECA ZD5522, a potent inhibitor of human and bovine lens aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aspirin and senile cataracts in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldose reductase inhibitors and cataract

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Monoamine oxidase inhibitors and other drugs as inhibitors of diamine oxidase from human placenta and pig kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

NADPH-oxidising activity in lens and erythrocytes in diabetic and nondiabetic patients with cataract

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Time-Dependent Inhibition of Diamine Oxidase by Carbonyl-Group Reagents and Urea

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldehyde dehydrogenase, aldose reductase, and free radical scavengers in cataract.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The penetration of Sorbinil, an aldose reductase inhibitor, into lens, aqueous humour and erythrocytes of patients undergoing cataract extraction

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Rat lens aldose reductase and polyol production

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Cortical cataract formation prevented by vitamin E and glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Vitamin C: an aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Synthesis of pyrrolo[3,4-c]pyridine derivatives possessing an acid group and their in vitro and in vivo evaluation as aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Site-specific inactivation of aldose reductase by 4-hydroxynonenal

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Neutrophil aldose reductase activity as a potential marker for neuropathy and cataract in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Studies on L-threose as substrate for aldose reductase: a possible role in preventing protein glycation

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldose reductase as a target for drug design: molecular modeling calculations on the binding of acyclic sugar substrates to the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Regulation of aldose reductase gene expression in renal cortex and medulla of rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Glucose tolerance tests in 200 patients with senile cataract

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Spiro[fluoreneisothiazolidin]one dioxides: new aldose reductase and L-hexonate dehydrogenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aminoguanidine does not inhibit aldose reductase activity in galactose-fed rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effects on rat renal osmolytes of extended treatment with an aldose reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Mechanism of aldose reductase inhibition: binding of NADP+/NADPH and alrestatin-like inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Catalysis of reduction of carbohydrate 2-oxoaldehydes (osones) by mammalian aldose reductase and aldehyde reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Stereospecificity of the hydrogen transfer catalyzed by human placental aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

ORE, a eukaryotic minimal essential osmotic response element. The aldose reductase gene in hyperosmotic stress

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Cloning, genomic organization, and osmotic response of the aldose reductase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Inhibitory effects of perillosides A and C, and related monoterpene glucosides on aldose reductase and their structure-activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Stimulation of glucosylated lens epithelial Na,K-ATPase by an aldose reductase inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The role of the superoxide anion as a toxic species in the erythrocyte

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Accumulation of xylitol in the mammalian lens is related to glucuronate metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The human aldose reductase gene maps to chromosome region 7q35

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Human aldose reductase: pK of tyrosine 48 reveals the preferred ionization state for catalysis and inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Human aldose reductase: subtle effects revealed by rapid kinetic studies of the C298A mutant enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Oxidized aldose reductase: in vivo factor not in vitro artifact

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Control of sorbitol metabolism in renal inner medulla of diabetic rats: regulation by substrate, cosubstrate and products of the aldose reductase reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Bovine lens aldehyde reductase (aldose reductase). Purification, kinetics and mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Increased Erythrocyte Aldose Reductase Activity in Type 1 Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effects of an aldose reductase inhibitor on erythrocyte fructose 3-phosphate and sorbitol 3-phosphate levels in diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Inhibition of aldose reductase by maesanin and related p-benzoquinone derivatives and effects on other enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effect of Polygonum hydropiper sulfated flavonoids on lens aldose reductase and related enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

1 reference

7 January 2021

The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

An aldose reductase inhibitor, TAT, prevents electroretinographic abnormalities and ADP-induced hyperaggregability in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The effect of an unsaturated-fat diet on cataract formation in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Pharmacokinetics of the aldose reductase inhibitor, zopolrestat, in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Highly selective aldose reductase inhibitors. 1. 3-(Arylalkyl)-2,4,5-trioxoimidazolidine-1-acetic acids

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-beta and protein kinase C activity in cultured mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Hormonal regulation of aldose reductase in rat ovary during the estrous cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Identification of a novel cis-element required for the constitutive activity and osmotic response of the rat aldose reductase promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Sequence of pig lens aldose reductase and electrospray mass spectrometry of non-covalent and covalent complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Comparative anatomy of the aldo-keto reductase superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Spirohydantoin inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Purified rat lens aldose reductase. Polyol production in vitro and its inhibition by aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Identification of an aldose reductase inhibitor site by affinity labeling

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The pharmacology of aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Matteuorienate A and B, two new and potent aldose reductase inhibitors from Matteuccia orientalis (Hook.) Trev

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2',5'-dioxospiro-[chroman-4,4'-imidazolidine]-2-carbox amide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effects of glucose and SNK-860, an aldose reductase inhibitor, on the polyol pathway and chemiluminescence response of human neutrophils in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Increased white cell aldose reductase mRNA levels in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Osmotic changes in experimental galactose cataracts

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Visual impairment in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Retinopathy in young-onset diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Regulation of glucose transporter (GLUT 3) and aldose reductase mRNA inbovine retinal endothelial cells and retinal pericytes in high glucose and high galactose culture

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Identification and characterization of multiple osmotic response sequences in the human aldose reductase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

AFAP-120. A variant form of the Src SH2/SH3-binding partner AFAP-110 is detected in brain and contains a novel internal sequence which binds to a 67-kDa protein

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Studies of anti-cataract drugs from natural sources. I. Effects of a methanolic extract and the alkaloidal components from Corydalis tuber on in vitro aldose reductase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Long-term induction of an aldose reductase protein by basic fibroblast growth factor in rat astrocytes in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The epidemiology of senile cataracts: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Identification of the reactive cysteine residue in human placenta aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

High-performance liquid chromatographic analysis of glucose, fructose, sorbitol and low levels of the aldose reductase inhibitor sorbinil in human lens and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Inhibition of naphthalene cataract in rats by aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Activation of erythrocyte aldose reductase in man in response to glycaemic challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

N-substituted spirosuccinimide, spiropyridazine, spiroazetidine, and acetic acid aldose reductase inhibitors derived from isoquinoline-1,3-diones. 2

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Alpha-crystallin-like molecular chaperone against the thermal denaturation of lens aldose reductase: the effect of divalent metal ions

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Study on anti-cataract drugs from natural sources. II. Effects of buddlejae flos on in vitro aldose reductase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Salfredins, new aldose reductase inhibitors produced by Crucibulum sp. RF-3817. I. Fermentation, isolation and structures of salfredins

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldose reductase is a major reductase for isocaproaldehyde, a product of side-chain cleavage of cholesterol, in human and animal adrenal glands.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

3-Deoxyglucosone reductase in dog adrenal glands. Identification as aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effect of treatment with an aldose-reductase inhibitor on symptomatic carpal tunnel syndrome in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Hypoglycemic and aldose reductase activity of Polichia campestris

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Potassium depletion modulates aldose reductase mRNA in rat renal inner medulla.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Antihyperglycemic effects of M16209, a novel aldose reductase inhibitor, in normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Quantitative determination of human aldose reductase by enzyme-linked immunosorbent assay. Immunoassay of human aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Multiplicity of dog kidney high-Km aldose reductase and conversion mechanism into aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Conversion of a NADPH-dependent aldehyde reducing enzyme into aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Search for naturally occurring substances to prevent the complications of diabetes. II. Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Cataract: refractive error, diabetes, and morphology

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Analysis of carbohydrates in lens, erythrocytes, and plasma by high-performance liquid chromatography of nitrobenzoate derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Modification of the glyoxalase system in streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Enzyme/crystallins: gene sharing as an evolutionary strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effects of site-directed mutations on the chaperone-like activity of alphaB-crystallin.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Ibuprofen protects alpha-crystallin against posttranslational modification by preventing protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The effect of aldose reductase inhibition with ponalrestat on the width of the capillary basement membrane in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldose reductase inhibition by ponalrestat (statil) does not prevent proteinuria in long-term diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldose reductase and retinal capillary basement membrane thickening

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Rho B-crystallin, an aldose reductase-like lens protein in the gecko Lepidodactylus lugubris

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

An aldose reductase homologous gene from barley: regulation and function.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Characterization of the osmotic response element of the human aldose reductase gene promoter.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Monkey 3-deoxyglucosone reductase: tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Polyol pathway in tissues of spontaneously diabetic Chinese hamsters (Cricetulus griseus) and the effect of an aldose reductase inhibitor, ONO-2235

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Minimizing spurious receptor-binding kinetics with modified proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Non-specific binding of advanced-glycosylation end-products to macrophages outweighs specific receptor-mediated interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Monitoring the progress of non-enzymatic glycation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Abnormal expression of aldose reductase mRNA in fiber cells of cataractous rat lens. Analysis by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Isolation of aldose reductase inhibitors from the flowers ofChrysanthemum boreale

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Diabetes and senile cataract

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Inhibition of cytochrome P-450 activity in rat liver microsomes by the naturally occurring flavonoid, quercetin

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

4-hydroxy-2,3-trans-nonenal induces transcription and expression of aldose reductase.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldose and aldehyde reductases in human tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats: effects of insulin or aldose reductase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Catabolite repression of induction of aldose reductase activity and utilization of mixed hemicellulosic sugars in Candida guilliermondii

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Identification of fructose 3-phosphate in the lens of diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Induction of aldose reductase gene expression in LEC rats during the development of the hereditary hepatitis and hepatoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

[Substrate specificity and inhibition by various compounds of aldose reductase II from rabbit lens]

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Methylglyoxal, glyoxalases and the development of diabetic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The oxidation of oxyhaemoglobin by glyceraldehyde and other simple monosaccharides.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

α-glucosidase and aldose reductase inhibitors: Constituents of cashew,Anacardium occidentale, nut shell liquids

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldose reductase inhibitors: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Aldose reductase inhibition and the phosphorus-31 profile of the intact diabetic rat lens

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effect of 24 weeks of treatment with epalrestat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Local improvement of electron-density maps.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Formation of Polyols by the Lens of the Rat with ‘Sugar’ Cataract

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Do aspirin-like analgesics protect against cataract? A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Molecular cloning of testicular 20 alpha-hydroxysteroid dehydrogenase: identity with aldose reductase.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Levels of expression of hexokinase, aldose reductase and sorbitol dehydrogenase genes in lens of mouse and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The utilization of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Refined 1.8 A structure of human aldose reductase complexed with the potent inhibitor zopolrestat

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Immunochemical characterization of aldo-keto reductases from human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Low apparent aldose reductase activity produced by monosaccharide autoxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

The autoxidation of glyceraldehyde and other simple monosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Effects of galactose feeding on aldose reductase gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Galactosemic neuropathy in transgenic mice for human aldose reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

Number and ultrastructure of epithelial cells in crypts and villi along the streptozotocin-diabetic small intestine: a quantitative study on the effects of insulin and aldose reductase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2897%2900013-X

7 January 2021

10.1016/S1350-9462(97)00013-X

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9695797

1 reference

5 February 2018